WO2022137637A1 - 水中油型乳化化粧料 - Google Patents
水中油型乳化化粧料 Download PDFInfo
- Publication number
- WO2022137637A1 WO2022137637A1 PCT/JP2021/029916 JP2021029916W WO2022137637A1 WO 2022137637 A1 WO2022137637 A1 WO 2022137637A1 JP 2021029916 W JP2021029916 W JP 2021029916W WO 2022137637 A1 WO2022137637 A1 WO 2022137637A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- mass
- total amount
- present
- acid
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 109
- 239000000463 material Substances 0.000 title abstract 6
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 24
- 239000000049 pigment Substances 0.000 claims abstract description 24
- 239000006097 ultraviolet radiation absorber Substances 0.000 claims abstract description 23
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims abstract description 21
- 229960001679 octinoxate Drugs 0.000 claims abstract description 21
- 150000001298 alcohols Chemical class 0.000 claims abstract description 12
- 239000006096 absorbing agent Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 41
- 239000002107 nanodisc Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 11
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 11
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 10
- 229940008099 dimethicone Drugs 0.000 claims description 9
- 230000002087 whitening effect Effects 0.000 claims description 8
- 230000005661 hydrophobic surface Effects 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 20
- 239000011248 coating agent Substances 0.000 abstract description 18
- 238000000576 coating method Methods 0.000 abstract description 18
- 239000003921 oil Substances 0.000 description 51
- 235000019441 ethanol Nutrition 0.000 description 42
- -1 polyoxyethylene Polymers 0.000 description 40
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 21
- 239000004094 surface-active agent Substances 0.000 description 20
- 239000008346 aqueous phase Substances 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 17
- 239000000203 mixture Substances 0.000 description 14
- 239000002211 L-ascorbic acid Substances 0.000 description 13
- 229960005070 ascorbic acid Drugs 0.000 description 13
- 238000003756 stirring Methods 0.000 description 12
- 235000000069 L-ascorbic acid Nutrition 0.000 description 11
- 235000001014 amino acid Nutrition 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 238000004945 emulsification Methods 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 230000001804 emulsifying effect Effects 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000011259 mixed solution Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 7
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 150000003384 small molecules Chemical class 0.000 description 7
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 7
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- ATFFFUXLAJBBDE-FQEVSTJZSA-N N-Stearoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O ATFFFUXLAJBBDE-FQEVSTJZSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 6
- 229940072873 stearoyl glutamic acid Drugs 0.000 description 6
- 229960000401 tranexamic acid Drugs 0.000 description 6
- 230000002776 aggregation Effects 0.000 description 5
- 239000003012 bilayer membrane Substances 0.000 description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- NUHMQHLCUWSBCS-UHFFFAOYSA-N 10-(16-methylheptadecoxy)-10-oxodecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCC(O)=O NUHMQHLCUWSBCS-UHFFFAOYSA-N 0.000 description 4
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 239000001685 glycyrrhizic acid Substances 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- IZZIWIAOVZOBLF-UHFFFAOYSA-N 5-methyloxysalicylic acid Natural products COC1=CC=C(O)C(C(O)=O)=C1 IZZIWIAOVZOBLF-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 238000010306 acid treatment Methods 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000007764 o/w emulsion Substances 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- AUZQQIPZESHNMG-UHFFFAOYSA-N 3-methoxysalicylic acid Chemical compound COC1=CC=CC(C(O)=O)=C1O AUZQQIPZESHNMG-UHFFFAOYSA-N 0.000 description 2
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 2
- MRIXVKKOHPQOFK-UHFFFAOYSA-N 4-methoxysalicylic acid Chemical compound COC1=CC=C(C(O)=O)C(O)=C1 MRIXVKKOHPQOFK-UHFFFAOYSA-N 0.000 description 2
- SKQOTPRMPUYWSH-FQEVSTJZSA-N CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O SKQOTPRMPUYWSH-FQEVSTJZSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- 230000006750 UV protection Effects 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 2
- 229960001630 diethylamino hydroxybenzoyl hexyl benzoate Drugs 0.000 description 2
- 229940031569 diisopropyl sebacate Drugs 0.000 description 2
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000008385 outer phase Substances 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229940082006 potassium cocoyl glutamate Drugs 0.000 description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical group OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940071136 stearoyl glutamate Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- IRVNEGRHQKGRGD-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O IRVNEGRHQKGRGD-WPXUHFOISA-N 0.000 description 1
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- MHUOEHQATDLJFZ-WPXUHFOISA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O MHUOEHQATDLJFZ-WPXUHFOISA-N 0.000 description 1
- KKYDYRWEUFJLER-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5,5,6,6,7,7,10,10,10-heptadecafluorodecyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)CCC(F)(F)F KKYDYRWEUFJLER-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- UAFHRUBCOQPFFM-UHFFFAOYSA-N 1-(aminomethyl)cyclohexane-1-carboxylic acid Chemical compound NCC1(C(O)=O)CCCCC1 UAFHRUBCOQPFFM-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- CECHHHFZXNTPMP-UHFFFAOYSA-N 2-(2,2-dimethylpropanoyloxy)ethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCOC(=O)C(C)(C)C CECHHHFZXNTPMP-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- KKDLMTFRMQVLMO-UHFFFAOYSA-N 2-heptylundecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCC)CCCCCCCCC KKDLMTFRMQVLMO-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- JUIYTAQAHOONSH-UHFFFAOYSA-N 2-hydroxy-4-propan-2-yloxybenzoic acid Chemical compound CC(C)OC1=CC=C(C(O)=O)C(O)=C1 JUIYTAQAHOONSH-UHFFFAOYSA-N 0.000 description 1
- IXKMJGZLCSWMTD-UHFFFAOYSA-N 2-hydroxy-4-propoxybenzoic acid Chemical compound CCCOC1=CC=C(C(O)=O)C(O)=C1 IXKMJGZLCSWMTD-UHFFFAOYSA-N 0.000 description 1
- AAUQLHHARJUJEH-UHFFFAOYSA-N 2-hydroxy-5-methoxybenzoic acid Natural products COC1=CC=CC(O)=C1C(O)=O AAUQLHHARJUJEH-UHFFFAOYSA-N 0.000 description 1
- VHCJSVNQEBEVMO-UHFFFAOYSA-N 2-hydroxy-5-propoxybenzoic acid Chemical compound CCCOC1=CC=C(O)C(C(O)=O)=C1 VHCJSVNQEBEVMO-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- CIHKVMHPDDJIIP-UHFFFAOYSA-N 2-methylperoxybenzoic acid Chemical compound COOC1=CC=CC=C1C(O)=O CIHKVMHPDDJIIP-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- PKYUNJWBVAXPMG-UHFFFAOYSA-N 3-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=CC(C(O)=O)=C1O PKYUNJWBVAXPMG-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- JBRMEFWJFBHUKG-UHFFFAOYSA-N 4-[(diaminomethylideneamino)methyl]cyclohexane-1-carboxylic acid Chemical compound NC(N)=NCC1CCC(C(O)=O)CC1 JBRMEFWJFBHUKG-UHFFFAOYSA-N 0.000 description 1
- RNGFVIMNTYOBTK-UHFFFAOYSA-N 4-butoxy-2-hydroxybenzoic acid Chemical compound CCCCOC1=CC=C(C(O)=O)C(O)=C1 RNGFVIMNTYOBTK-UHFFFAOYSA-N 0.000 description 1
- DVZPQHRWOUXUPU-UHFFFAOYSA-N 4-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(C(O)=O)C(O)=C1 DVZPQHRWOUXUPU-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- ZZKFPIOJAOEMQL-UHFFFAOYSA-N 5-ethoxy-2-hydroxybenzoic acid Chemical compound CCOC1=CC=C(O)C(C(O)=O)=C1 ZZKFPIOJAOEMQL-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- UEQVLKWMHAYVLO-MGCOHNPYSA-N C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O Chemical compound C1C[C@@H](CN)CC[C@@H]1C(=O)OC1=CC=C(O)C=C1C(O)=O UEQVLKWMHAYVLO-MGCOHNPYSA-N 0.000 description 1
- AVWTXYWHGFHGQD-ZKCHVHJHSA-N CNC(=O)[C@H]1CC[C@H](CN)CC1 Chemical compound CNC(=O)[C@H]1CC[C@H](CN)CC1 AVWTXYWHGFHGQD-ZKCHVHJHSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- KIENGQUGHPTFGC-JLAZNSOCSA-N L-ascorbic acid 6-phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O KIENGQUGHPTFGC-JLAZNSOCSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- YQINWFJNFJEWHH-UCLHFMLVSA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCC(O)=O YQINWFJNFJEWHH-UCLHFMLVSA-N 0.000 description 1
- GAKOHFNTEXOHTP-RXSVEWSESA-N OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.OP(O)(=O)OP(O)(=O)OP(O)(O)=O GAKOHFNTEXOHTP-RXSVEWSESA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical group OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229920004482 WACKER® Polymers 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000001343 alkyl silanes Chemical class 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000013011 aqueous formulation Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940072065 ascorbic acid 2-sulfate Drugs 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- VQWFNAGFNGABOH-UHFFFAOYSA-K chromium(iii) hydroxide Chemical compound [OH-].[OH-].[OH-].[Cr+3] VQWFNAGFNGABOH-UHFFFAOYSA-K 0.000 description 1
- 229910000152 cobalt phosphate Inorganic materials 0.000 description 1
- LFSBSHDDAGNCTM-UHFFFAOYSA-N cobalt(2+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[Ti+4].[Co+2] LFSBSHDDAGNCTM-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 1
- SBRXLTRZCJVAPH-UHFFFAOYSA-N ethyl(trimethoxy)silane Chemical compound CC[Si](OC)(OC)OC SBRXLTRZCJVAPH-UHFFFAOYSA-N 0.000 description 1
- OOCHRDQHTSHBJV-UHFFFAOYSA-N ethyl-dimethoxy-(2,2,2-trifluoroethoxy)silane Chemical compound CC[Si](OC)(OC)OCC(F)(F)F OOCHRDQHTSHBJV-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- CZWLNMOIEMTDJY-UHFFFAOYSA-N hexyl(trimethoxy)silane Chemical compound CCCCCC[Si](OC)(OC)OC CZWLNMOIEMTDJY-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical class FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 description 1
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- QXQOYJODXQCGON-UHFFFAOYSA-M potassium;2-methylperoxybenzoate Chemical compound [K+].COOC1=CC=CC=C1C([O-])=O QXQOYJODXQCGON-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- NMEPHPOFYLLFTK-UHFFFAOYSA-N trimethoxy(octyl)silane Chemical compound CCCCCCCC[Si](OC)(OC)OC NMEPHPOFYLLFTK-UHFFFAOYSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Definitions
- the present invention relates to an oil-in-water emulsified cosmetic that can stably blend an ultraviolet absorber and a pigment and has improved cosmetic effects such as familiarity with the skin, uniformity of a coating film, and lack of thick coating feeling. ..
- Some amphipathic substances form spherical closures consisting of bilayer membranes (lamella liquid crystals) in the aqueous phase, and such bilayer membrane closures are called vesicles. Vesicles can retain water-soluble components inside the closed body, oil-based components can be retained inside the bilayer membrane, and can be expected to have effects such as improving the stability of the system, so they are the basis of cosmetics. It is used as an agent.
- Silicone-based surfactants can be mentioned as amphipathic substances that form vesicles.
- the vesicle formed by the silicone-based surfactant is preferably used because it has advantages such as a composition having no stickiness and a good usability and being easy to prepare.
- Patent Document 1 the stability of vesicles was improved by adding a water-soluble low-molecular-weight surfactant to a vesicle-containing aqueous solution previously formed by mixing an aqueous formulation and a silicone-based surfactant. Is described. Further, Patent Document 2 describes that the stability of the vesicle is improved by adding the anionic surfactant after forming the vesicle made of the silicone-based surfactant.
- Patent Documents 3 and 4 a vesicle is formed by using a specific polyoxyethylene hydrogenated castor oil derivative as an amphipathic substance in an oil-in-water emulsified cosmetic, and this is used as an emulsifying base to emulsify. It is stated that an oil-in-water emulsified cosmetic with excellent stability was obtained.
- the emulsified composition has sufficient stability over time, and there is a problem in blending a large amount of ultraviolet absorbers and pigments in the oil phase.
- the present invention makes it possible to stably blend an ultraviolet absorber and a pigment in an oil-in-water emulsified composition, and improves cosmetic effects such as familiarity with the skin, uniformity of a coating film, and lack of thick coating feeling. It is an object of the present invention to provide a water-based oil-type emulsified cosmetic.
- a vesicle formed by a specific silicone-based surfactant in the presence of a specific aqueous component in an oil-in-water emulsified composition as a precursor.
- vibration stability is significantly improved, and it is said that it fits well on the skin, the coating is uniform and there is no feeling of thick coating.
- ethylhexyl methoxycinnamate as an ultraviolet absorber
- nanodisc is a flat plate-shaped lamellar liquid crystal closure whose precursor is a vesicle (lamellar liquid crystal spherical closure) formed by an amphipathic substance, and contains a water-soluble component inside the closure. However, it refers to a substance having an amphipathic group at the edge portion. Nanodiscs exist as precursor vesicles in oil-free compositions, and the vesicles undergo structural changes (hereinafter also referred to as "transfers”) to nanodisks by adding oil and emulsifying.
- an anionic surfactant and an oil component are added to a vesicle aqueous dispersion obtained by mixing an aqueous component selected from a monohydric alcohol and a divalent alcohol with a polyoxyalkylene-modified silicone to form a vesicle. It is obtained by adding and dispersing while applying a strong stirring force.
- Nanodiscs exist in a state of being adsorbed on the oil-water interface in an emulsified state, and contribute to emulsification stability.
- the amphipathic substance forming the vesicle is a silicone-based surfactant
- the nanodisk of the present invention is also referred to as “silicone nanodisk”.
- the present invention (A) Aqueous component selected from monohydric alcohols and divalent alcohols, (B) Polyoxyalkylene modified silicone, (C) Oil containing ethylhexyl methoxycinnamate as an ultraviolet absorber, (D) Pigments having a hydrophobic surface and (E) Containing anionic surfactant,
- Aqueous component selected from monohydric alcohols and divalent alcohols,
- D Pigments having a hydrophobic surface and
- E Containing anionic surfactant
- the aqueous component (A) is monohydric alcohol alone, it is 1 to 15% by mass with respect to the total amount of cosmetics, and when dihydric alcohol is alone, it is 1 to 20% by mass with respect to the total amount of cosmetics.
- the total amount is 1 to 45% by mass with respect to the total amount of cosmetics.
- an oil-in-water emulsified cosmetic having a mass ratio of ethylhexyl methoxycinnamate of 40% or more with respect to the total amount of ultraviolet absorbers blended in the oil (C). Further, the oil-in-water emulsified cosmetic according to the present invention is characterized in that nanodisks made of the (B) polyoxyalkylene-modified silicone are attached to the oil-water interface.
- the cosmetic according to the present invention is an oil-in-water emulsion having a high emulsifying power by having the above composition, so that an ultraviolet absorber and a pigment can be stably blended in the oil phase.
- it has excellent vibration stability as compared with the conventional emulsification by vesicles, and can improve cosmetic effects such as familiarity with the skin, uniformity of the coating film, and lack of thick coating feeling. Therefore, it is possible to realize a cosmetic that is more suitable for carrying.
- the silicone nanodisc according to the present invention has sufficient emulsifying power, it is also possible to add a water-soluble agent such as a salt-type whitening agent, which tends to have poor stability when added to the aqueous phase, which is usually the outer phase. It becomes.
- a water-soluble agent such as a salt-type whitening agent
- the cosmetic according to the present invention comprises (A) an aqueous component selected from a monohydric alcohol and a dihydric alcohol, (B) a polyoxyalkylene-modified silicone, and (C) an oil containing ethylhexyl methoxycinnamate as an ultraviolet absorber. D) It is characterized by containing a pigment having a hydrophobic surface and (E) an anionic surfactant.
- the (A) aqueous component (hereinafter, may be simply referred to as "(A) component”) blended in the cosmetic according to the present invention is one or more selected from monohydric alcohol and dihydric alcohol.
- the monohydric alcohol is not particularly limited as long as it is usually used for cosmetics, and examples thereof include ethyl alcohol (ethanol), normal propyl alcohol, and isopropyl alcohol, and in the present invention, ethyl alcohol is preferable.
- the divalent alcohol is not particularly limited as long as it is usually used for cosmetics, but examples thereof include 1,3-butylene glycol, dipropylene glycol and the like, and dipropylene glycol is preferable in the present invention.
- the surface of the spherical vesicles formed by the surfactant is entirely covered with hydrophilic groups, but since nanodiscs have lipophilic groups at the edges, it is difficult to generate nanodisks in water.
- the surfactant polyether-modified silicone in the present invention
- the surfactant is hydrophilized by the solvent effect, and as a result, the transfer from spherical vesicles to nanodisks is promoted.
- the blending amount is 1 to 15% by mass with respect to the total amount of cosmetics
- the divalent alcohol is used alone
- the blending amount is 1 to 15% by mass with respect to the total amount of cosmetics. It is 1 to 20% by mass.
- the total blending amount is 1 to 45% by mass, preferably 1 to 35% by mass, based on the total amount of the cosmetics. More preferably, the monohydric alcohol and the dihydric alcohol concentration satisfying the following formula (1) are blended up to the upper limit.
- the blending amount of monohydric alcohol alone, the blending amount of dihydric alcohol alone, and the total blending amount of monohydric alcohol and divalent alcohol is less than 1% by mass, vesicles may not be generated or the structure may be disturbed and emulsification may not be possible. .. Further, when the blending amount of the monohydric alcohol alone exceeds 15% by mass or when the blending amount of the dihydric alcohol alone exceeds 20% by mass, the blending ratio of the monohydric alcohol and the dihydric alcohol is further in the above formula (1).
- the (B) polyoxyalkylene-modified silicone (hereinafter, may be simply referred to as “component (B)”) blended in the cosmetic according to the present invention has a polysiloxane structure as a hydrophobic group and a polyoxyalkylene as a hydrophilic group. It is a surfactant having a structure, and is preferably a water-soluble silicone-based surfactant in which a part of the methyl group of dimethicone is replaced with polyethylene glycol. Specifically, it is expressed by the following equation (2).
- R 1 is hydrogen or an alkyl group having 1 to 6 carbon atoms, and may be the same or independently different from each other.
- At least one of A is the formula (3): -(CH 2 ) a- (C 2 H 4 O) b- (C 3 H 6 O) c-R 2 (3)
- the other A is a hydrogen or an alkyl group having 1 to 6 carbon atoms, which may be the same or independently different from each other.
- R 2 in the formula (3) is hydrogen or an alkyl group having 1 to 6 carbon atoms, a is an integer of 1 to 6, b is an integer of 0 to 50, c is an integer of 0 to 50, and b + c is at least 5 or more. be.
- m is an integer of 1 to 200
- n is an integer of 0 to 50.
- the (B) polyoxyalkylene-modified silicone of the present invention preferably has an HLB of less than 10 in the HLB calculation according to the Griffin formula.
- PEG-12 dimethicone in which c is 0 and b is 12 in the above formula (3) is particularly preferable. Further, it is more preferable that PEG-12 dimethicone has an HLB of less than 10.
- Examples of commercially available products of PEG-12 dimethicone include DOWNSIL TM ES-5373, SH3772M, SH3773M, SH3775M (all manufactured by Dow Toray), IM-22 (manufactured by Wacker Chemical Co., Ltd.) and the like.
- the blending amount of the component (B) is not particularly limited as long as it can form a vesicle that is a precursor of nanodisks, but is, for example, 0.1 to 5.0% by mass, preferably 0, based on the total amount of cosmetics. It is 0.3 to 3.0% by mass, more preferably 0.8 to 2.0% by mass. If the blending amount is less than 0.1% by mass, vesicles may not be sufficiently formed, and if it exceeds 5.0% by mass, the stability of the vesicles may be inferior.
- the cosmetic according to the present invention contains nanodiscs made of the surfactant of the component (B).
- Vesicles which are precursors of nanodisks, can be formed by a conventional method. Specifically, a vesicle composed of the component (B) is formed by mixing and stirring (A) the aqueous component and (B) the polyoxyalkylene-modified silicone.
- a vesicle composed of the component (B) is formed by mixing and stirring (A) the aqueous component and (B) the polyoxyalkylene-modified silicone.
- water or an aqueous component usually used in cosmetics may be blended in an amount within a range that does not impair the stability of the vesicle.
- the average particle size of the vesicle is not particularly limited, but is usually about 30 nm to 150 nm.
- the (C) oil component (hereinafter, may be simply referred to as “(C) component”) contained in the cosmetics according to the present invention refers to an oil component containing at least ethylhexyl methoxycinnamate as an ultraviolet absorber.
- ethylhexyl methoxycinnamate which is an ultraviolet absorber
- ethylhexyl methoxycinnamate may be used alone, or in addition to ethylhexyl methoxycinnamate, other ultraviolet absorbers usually used in sunscreen cosmetics and others.
- the oil content of the above may be appropriately combined and blended without particular limitation.
- the ratio of ethylhexyl methoxycinnamate to the total amount of the ultraviolet absorbers is 40% or more in terms of mass ratio. ..
- the vibration stability is remarkably lowered. Since ethylhexyl methoxycinnamate may be used alone as the ultraviolet absorber to be blended in the cosmetic of the present invention, the upper limit of the ratio of ethylhexyl methoxycinnamate to the total amount of the UV absorber is 100. %.
- UV absorbers that can be formulated in combination with ethylhexyl methoxycinnamate include octocrylene, dimethicodiethylbenzalmaronate, polysilicone-15, t-butylmethoxydibenzoylmethane, ethylhexyltriazone, diethylaminohydroxybenzoyl benzoyl.
- Hexyl acid bisethylhexyloxyphenol methoxyphenyltriazine, oxybenzon-3, methylenebisbenzotriazolyltetramethylbutylphenol, phenylbenzimidazole sulfonic acid, homosalate, ethylhexyl salicylate, terephthalylidenedicanfursulfonic acid, drometrizoletri
- organic ultraviolet absorbers such as siloxane.
- the ultraviolet absorber used in the present invention may be used alone or in combination of two or more.
- the amount of the ultraviolet absorber to be blended in the cosmetic according to the present invention is 1 to 40% by mass, preferably 3 to 30% by mass, and more preferably 5 to 25% by mass with respect to the total amount of the cosmetic. be. If the blending amount of the UV absorber is less than 1% by mass, it is difficult to obtain a sufficient UV protection effect, and even if the blending amount exceeds 40% by mass, the UV protection effect cannot be expected to increase in proportion to the blending amount, and the stability is rather stable. It is not preferable because it deteriorates usability.
- the oil (C) of the present invention may further contain one or more selected from hydrocarbon oils, ester oils and silicone oils.
- hydrocarbon oil examples include isododecane, isohexadecane, hydrogenated polydecene, isoparaffin, liquid paraffin, ozokerite, squalane, pristane, paraffin, ceresin, squalane, petrolatum, microcrystalline wax and the like.
- ester oil examples include isopropyl myristate, cetyl ethylcaproate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, and cetyl lactate.
- Myristyl Lactate Lanoline acetate, Isocetyl stearate, Isocetyl isostearate, Cholesteryl 12-hydroxystearate, Ethylene glycol di-2-ethylcaproate, Dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, Neopentyl dicaprate Glycol, diisostearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylcaproate, trimethylolpropane triisostearate, glycerin triisostearate, pentaerythrityl tetraethylhexanoate, triethylhexa Noin (glyceryl tri-2-ethylcaproate), cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glycerin trim
- silicone oil examples include chain polysiloxane (eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.) and cyclic polysiloxane (eg, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethyl, etc.).
- chain polysiloxane eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.
- cyclic polysiloxane eg, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethyl, etc.
- Silicone resin forming a three-dimensional network structure, silicone rubber, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.), acrylic Examples include silicones.
- the blending amount of the oil is not particularly limited as long as it is an amount normally used for blending the pigment in the oil phase, and for example, it may be 1 to 40% by mass with respect to the total amount of cosmetics. (C) If the blending amount of the oil exceeds 40% by mass, the stability and usability tend to decrease.
- the small molecule oil when a small molecule oil is blended as an oil, the small molecule oil is added to the total blending amount of the oil excluding the ultraviolet absorber.
- the proportion is preferably 50% or less in terms of mass ratio. Since it is not necessary to add the small molecule oil as the oil (C) of the present invention, the range of the ratio of the small molecule oil to the total amount of the oil excluding the ultraviolet absorber is 0 to 50%.
- the small molecule oil content refers to an oil content having a volatilization rate at 25 ° C. and a weight change rate of 30% or more per hour.
- the volatilization rate refers to the value of the rate of change in weight per hour measured under the condition of 25 ° C. by placing a filter paper on a glass petri dish, dropping about 0.2 g of a sample, and using a gravimetric method.
- Specific examples of the small molecule oil include isododecane, low-viscosity volatile silicone (low-viscosity dimethicone) having an average degree of polymerization of less than 650, and the like.
- Examples of commercially available small molecule oil products include Creasil ID CG (manufactured by Shima Trading Co., Ltd.) and KF-96L-1.5CS (manufactured by Shin-Etsu Chemical Co., Ltd.).
- the volatilization rate of Creasil ID CG is 90% or more, and the volatilization rate of KF-96L-1.5CS is about 50%.
- the (D) pigment (hereinafter, may be simply referred to as “(D) component”) blended in the cosmetic according to the present invention is not particularly limited, but may be appropriately selected from those usually used in cosmetics. It refers to an inorganic pigment that can be formed and has a hydrophobic surface. Specific examples include iron oxide (Bengala), iron titanate, ⁇ -iron oxide, iron yellow oxide, ocher, black iron oxide, carbon black, lower-order titanium oxide, mango violet, cobalt violet, chromium oxide, and chromium hydroxide. , Cobalt titanate, ultramarine, dark blue, etc.
- the pigment (D) of the present invention it is preferable to use pigment grade iron oxide such as yellow iron oxide, red iron oxide and black iron oxide, pigment grade titanium oxide and the like.
- the pigment grade means a pigment having an average particle size of 100 nm to 1 ⁇ m.
- the pigment (D) used in the present invention may be either untreated or hydrophobized as long as the surface of the particles is hydrophobic.
- Methods for hydrophobizing surface treatment of pigments include silicone oils such as methylhydrogenpolysiloxane, dimethylpolysiloxane, and methylphenylpolysiloxane, methyltrimethoxysilane, ethyltrimethoxysilane, hexyltrimethoxysilane, and octyltrimethoxysilane.
- Alkylsilane such as trifluoromethylethyltrimethoxysilane, fluoroalkylsilane such as heptadecafluorodecyltrimethoxysilane, tetramethyltetrahydrogencyclotetrasiloxane and trimethyltrihydro described in JP-A-61-268763.
- Silicone treatment with cyclic siloxanes such as gencyclotrisiloxane; Fluorocompound treatment with perfluoroalkylphosphates, perfluoroalcohols, etc .; N-acylglutamic acid, N-acylaspartic acid, N-acyllysine, etc.
- Examples thereof include amino acid treatment; lecithin treatment; metal soap treatment; fatty acid treatment; alkylphosphate ester treatment.
- a silicone treatment and an amino acid treatment are preferably used as the hydrophobic surface treatment of the pigment.
- OTS-2 LL-100P manufactured by Daito Kasei Kogyo Co., Ltd.
- NHS-Yellow LL-100P manufactured by Miyoshi Kasei Kogyo Co., Ltd.
- black iron oxide A certain OTS-2 BL-100P (manufactured by Daito Kasei Kogyo Co., Ltd.), NHS-Black BL-100P (manufactured by Miyoshi Kasei Kogyo Co., Ltd.), OTS-2 Bengala No. which is red iron oxide.
- 216P (manufactured by Daito Kasei Kogyo Co., Ltd.), NHS-Red R516P (manufactured by Miyoshi Kasei Kogyo Co., Ltd.) and the like can be mentioned.
- examples of commercially available products of the hydrophobized pigment grade titanium oxide include OTS-2 SACHTLEBEN RC402 (manufactured by Daito Kasei Kogyo Co., Ltd.) and NHS-Titanium CR-50 (manufactured by Miyoshi Kasei Kogyo Co., Ltd.).
- the blending amount of the component (D) is not particularly limited as long as a desired color is obtained, but is usually 1% by mass or more, for example, 1 to 30% by mass, preferably 1 to 20% by mass with respect to the total amount of cosmetics. If the blending amount is less than 1% by mass, sufficient color cannot be obtained, and if it exceeds 30% by mass, the stability tends to deteriorate.
- the cosmetic according to the present invention is a powder type composition in oil in water in which the pigment (D) is dispersed in oil droplets which are the internal phase.
- the oil phase is preferably 1 to 50% by mass with respect to the total amount of the cosmetics.
- the (E) anionic surfactant (hereinafter, may be simply referred to as "(E) component") blended in the cosmetics according to the present invention may be any one usually used for cosmetics, and the above-mentioned ( B) A surfactant other than a silicone-based surfactant such as polyoxyalkylene-modified silicone, which has an anionic hydrophilic group such as a carboxylic acid, a sulfonic acid, and a surfactant having a phosphoric acid structure.
- the formulation of anionic surfactant stabilizes the nanodisc.
- an anionic surfactant having a Krafft temperature higher than room temperature.
- the silicone-based surfactant and the anionic surfactant are likely to mix and interact with each other, which tends to prevent the transfer from the vesicle to the nanodisc. be.
- a sulfonate-type anionic surfactant is preferable.
- the sulfonate-type anionic surfactant include sulfosuccinic acid diester salt, alkylallyl sulfonate, alkyl ether sulfonate, sulfosuccinic acid ester salt, acylmethyl taurine salt, acyl taurine salt, potassium cetyl phosphate, and potassium cocoyl glutamate. And so on. Among them, it is preferable to select and use from acylmethyltaurine salt, potassium cetylphosphate and potassium cocoylglutamate.
- N-acylmethyltaurine salt as (E) anionic surfactant.
- N-acylmethyl taurine salts represented by the following formula (4) the N-stearoyl-N-methyl taurine salt is preferable.
- the blending amount of the component (E) is preferably 0.01 to 1% by mass, more preferably 0.01 to 0.1% by mass, and 0.01 to 0. It is more preferably 06% by mass. If the blending amount is less than 0.01% by mass, the nanodisk may not be sufficiently stable, and if it exceeds 1% by mass, the vesicle that is the precursor of the nanodisk is solubilized or the formation of the nanodisk is hindered. In some cases. Further, the mixing amount ratio of (B) polyoxyalkylene-modified silicone and (E) anionic surfactant is 1: 0 in terms of mass ratio. It is preferably 01 to 1: 0.06.
- a whitening agent is added to sunscreen cosmetics, but it is generally known that when a salt-type whitening agent is added to the aqueous phase, which is the outer phase, the stability tends to deteriorate.
- the cosmetic according to the present invention is emulsified by nanodiscs formed of a specific silicone-based surfactant, and the emulsifying power is enhanced by adding a specific oil, so a salt-type whitening agent is added to the aqueous phase. Even so, it has the effect of being excellent in vibration stability.
- the (F) whitening agent (hereinafter, may be simply referred to as "(F) component”) blended in the cosmetic according to the present invention is not particularly limited as long as it is normally blended in the cosmetic.
- Specific examples include L-ascorbic acid and its derivatives, tranexamic acid and its derivatives, alkoxysalicylic acid and its derivatives, glycyrrhizic acid and its derivatives, nicotinic acid and its derivatives, and the like.
- one kind or a combination of two or more kinds of the above-mentioned agents may be blended.
- L-ascorbic acid monoalkyl esters such as L-ascorbic acid monostearate, L-ascorbic acid monopalmitate, and L-ascorbic acid monoolate; L-ascorbic acid monophosphate ester, L.
- L-L-ascorbic acid monoesters such as ascorbic acid-2-sulfate ester
- L-ascorbic acid dialkyl esters such as L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid diolate
- L-ascorbic acid tri L-ascorbic acid trialkyl esters such as stearate, L-ascorbic acid tripalmitate, L-ascorbic acid triolate
- L-ascorbic acid triesters such as L-ascorbic acid triphosphate
- L-ascorbic acid 2 -L-ascorbic acid glucosides such as glucoside can be mentioned.
- L-ascorbic acid, L-ascorbic acid phosphate ester, L-ascorbic acid-2-sulfate ester, L-ascorbic acid 2-glucoside and salts thereof are preferably used.
- tranexamic acid Derivatives of tranexamic acid include dimers of tranexamic acid (eg, trans-4- (trans-aminomethylcyclohexanecarbonyl) aminomethylcyclohexanecarboxylic acid, etc.), esters of tranexamic acid and hydroquinone (eg, 4).
- tranexamic acid and a salt thereof are preferably used.
- the derivative of alkoxysalicylic acid is one in which the hydrogen atom at any of the 3-position, 4-position or 5-position of salicylic acid is substituted with an alkoxy group, and the alkoxy group as the substituent is preferably a methoxy group, an ethoxy group, or the like. It is any one of a propoxy group, an isopropoxy group, a butoxy group and an isobutoxy group, and more preferably a methoxy group or an ethoxy group.
- compound names include 3-methoxysalicylic acid, 3-ethoxysalicylic acid, 4-methoxysalicylic acid, 4-ethoxysalicylic acid, 4-propoxysalicylic acid, 4-isopropoxysalicylic acid, 4-butoxysalicylic acid, and 5-methoxysalicylic acid. , 5-ethoxysalicylic acid, 5-propoxysalicylic acid and the like.
- methoxysalicylic acid and a salt thereof are preferably used.
- Examples of the derivative of glycyrrhizic acid include salts of glycyrrhizic acid and esters of glycyrrhizic acid and higher alcohols.
- glycyrrhizic acid and salts thereof are preferably used.
- the salt of the above-mentioned drug is not particularly limited, and examples thereof include alkali metal salts such as sodium salt, potassium salt and calcium salt, alkaline earth metal salts, ammonium salts, amino acid salts and the like.
- nicotinic acid and its derivatives examples include nicotinic acid, benzyl nicotinate, nicotinic acid amide, and dl- ⁇ -tocopherol nicotinate. Nicotinamide is preferably used in the present invention.
- the blending amount of the whitening agent is 0.05 to 10% by mass, preferably 0.1 to 7% by mass, and more preferably 0.5 to 5% by mass with respect to the total amount of the cosmetic. If the blending amount is less than 0.05% by mass, it is difficult to obtain a sufficient medicinal effect, and if it exceeds 10% by mass, the stability and usability tend to deteriorate.
- the (F) whitening agent of the present invention may be dissolved or dispersed in the aqueous phase together with other aqueous components.
- the cosmetic according to the present invention may contain one or more dispersants.
- the dispersant include sorbitan sesquiisostearate, isostearic acid, palmitic acid, polyhydroxystearic acid and the like.
- sorbitan sesquiisostearate and isostearic acid are exemplified as particularly suitable ones, and one or both of them may be blended.
- the dispersant is a selective compounding ingredient in the cosmetic of the present invention, it is not always necessary to blend it, but when it is blended, the effect of the blending is recognized and the blending amount is large. It is preferable to mix the mixture to the extent that no adverse effects such as excessive deterioration of usability are observed.
- the suitable blending amount of the dispersant in the cosmetic according to the present invention is preferably about 0.01 to 1% by mass with respect to the total amount of the cosmetic.
- the water to be blended in the cosmetic according to the present invention is selected as necessary, such as ion-exchanged water, purified water, tap water, and natural water.
- the blending amount is the remaining amount (mass% with respect to the total amount of cosmetics) with respect to the sum of the essential ingredient according to the present invention and other optional blending ingredients. Generally, about 30 to 70% by mass is preferable with respect to the total amount of cosmetics.
- the oil-in-water emulsified cosmetic according to the present invention includes, in addition to the above-mentioned ingredients, any other additive ingredients usually used for external skin preparations such as cosmetics and pharmaceuticals, as long as the purpose and effect of the present invention are not impaired.
- any other additive ingredients usually used for external skin preparations such as cosmetics and pharmaceuticals, as long as the purpose and effect of the present invention are not impaired.
- Powder components, fragrances and the like can be appropriately blended as needed.
- the present invention is not limited to these examples.
- (B) polyoxyalkylene-modified silicone is sufficiently mixed with (A) an aqueous component, and then the mixed solution is water containing an aqueous component other than (A) component. It can be produced as a vesicle aqueous dispersion by dropping the mixture into the phase while stirring.
- the mixed state of the (B) polyoxyalkylene-modified silicone and the (A) aqueous component may be as long as it can be confirmed that the mixed solution is transparent and in a one-phase state. For example, mixing is performed at room temperature to 90 ° C. for 1 to 30 minutes. It can be achieved by doing.
- vesicle particles having an average particle size of 30 to 150 nm measured by a dynamic light scattering method can be obtained.
- the vesicle according to the present invention can also be produced in a form in which an oily component is retained inside the bilayer membrane of the vesicle by a conventional method.
- the vesicle according to the present invention is oil-soluble by adding and mixing an oil-soluble component such as a fragrance in the step of mixing (B) polyoxyalkylene-modified silicone and (A) an aqueous component. It may be produced as a vesicle in which the component is retained in the bilayer membrane of the vesicle.
- the oil-in-water emulsified cosmetic according to the present invention is emulsified by nanodiscs transferred from vesicles by adding an anionic surfactant and oil to the aqueous phase containing vesicles and dispersing while applying strong stirring force. It was done.
- the cosmetic of the present invention is stabilized by a three-phase structure of aqueous phase-nanodisc phase-oil phase in which nanodisks (phases) are attached to oil phases (oil droplets). Therefore, the oil-in-water emulsified cosmetic according to the present invention is characterized in that nanodiscs made of polyoxyalkylene-modified silicone are attached (localized) around the oil-water interface, that is, around the oil droplets made of the oil phase. ..
- the major axis of the nanodisk is 20 nm to 1000 nm.
- the three-phase structure of the aqueous phase-nanodisc phase-oil phase in the oil-in-water emulsified cosmetic according to the present invention can be formed by a conventional method. That is, under stirring, polyoxyalkylene-modified silicone was dropped onto an aqueous component to form vesicle particles to obtain a vesicle aqueous dispersion, and an oily component separately mixed and dissolved with an anionic surfactant in this vesicle aqueous dispersion. Is added and dispersed with a strong stirring force, the vesicles are transferred to the nanodisks, forming a three-phase structure of aqueous phase-nanodisk phase-oil phase.
- Oil droplets consisting of oily components are emulsified and dispersed in the aqueous phase, and nanodisks are localized on the surface of the oil droplet particles, so that the emulsification stability is excellent and the feeling of use (freshness, non-stickiness) is also improved.
- the stirring device used for stirring is not particularly limited, and for example, a homomixer, a disper, or the like can be used.
- the vesicle particles formed in the aqueous phase can be molded into a sufficiently fine particle size by applying a strong share with the above-mentioned homomixer or the like, and uniformly dispersed in the aqueous phase.
- the degree of strong share is not particularly limited, but is usually about 5 minutes under the condition of 7,000 to 12,000 rpm by a homomixer.
- the cosmetic of the present invention is obtained by forming vesicle particles in an aqueous phase, adding an anionic surfactant to the vesicle dispersion, and then adding an oily component to emulsify. Therefore, the method for producing an oil-in-water emulsified cosmetic according to the present invention is obtained by a vesicle forming step of mixing (A) an aqueous component and (B) a polyoxyalkylene-modified silicone to form a vesicle, and a vesicle forming step.
- aqueous component and (B) a polyoxyalkylene-modified silicone are previously dissolved, and the solution is mixed with the remaining aqueous phase components to disperse the vesicles in the aqueous phase.
- a liquid may be obtained, or the vesicles are dispersed in the aqueous phase by mixing and stirring (B) the polyoxyalkylene-modified silicone in the aqueous phase containing (A) an aqueous component and an aqueous component other than (A).
- a vesicle dispersion may be obtained.
- the cosmetic according to the present invention has a fresh feeling of use peculiar to an oil-in-water emulsion, and has the effect of improving the familiarity with the skin, the uniformity of the coating film, and the lack of thick coating.
- the nanodisc-containing emulsion according to the present invention can be blended with a large amount of oil that cannot be blended with a normal solubilized product, yet a refreshing feeling of use can be obtained.
- the cosmetic according to the present invention is suitably used in various dosage forms such as creamy, milky liquid, and liquid.
- a product form it can be a makeup base containing a pigment, a foundation, an eyeliner, an eyeshadow, or other makeup cosmetics.
- the present invention will be described in more detail with reference to examples below, but the present invention is not limited thereto.
- the blending amount is shown in mass% with respect to the system in which the component is blended.
- Vibration stability 30 ml of the prepared sample was placed in a resin tube, vibrated for 30 minutes under the condition of 10 Hz or higher, and the emulsified separation and powder aggregation state of the sample after standing were visually observed. The evaluation was based on the following criteria. A: No emulsification destruction or powder agglomeration is observed. B: Emulsification destruction and powder agglomeration are rarely seen. C: Emulsification destruction and powder agglomeration are observed. D: Emulsification destruction and powder agglomeration are severely observed.
- Examples 1 to 4, comparative examples 1 to 7 An oil-in-water emulsified cosmetic having the composition shown in Table 1 was prepared. Specifically, the oil-in-water emulsified cosmetic of Comparative Example 1 is obtained by adding a mixed solution in which an oily component and a powder component are stirred and mixed separately to a mixed solution of an aqueous component obtained by stirring and mixing separately. Obtained. On the other hand, ethanol and an amphoteric substance (polyoxyalkylene-modified silicone, polyoxyethylene cured castor oil) forming a vesicle are mixed and stirred, and then other aqueous components are mixed to obtain an aqueous phase solution, and this aqueous phase is obtained.
- an amphoteric substance polyoxyalkylene-modified silicone, polyoxyethylene cured castor oil
- Examples 1 to 4 are obtained by adding an anionic surfactant to the solution to obtain a mixed solution, and by dispersing the oil phase solution obtained by separately mixing the oily component and the powder component in the mixed solution with stirring. And the oil-in-water emulsified cosmetics of Comparative Examples 2 to 7 were obtained.
- the prepared sample was evaluated for vibration stability and cosmetic effect according to the above-mentioned evaluation method. The results are shown in the table.
- the stearoxyhydroxypropylmethylcellulose in the table is a thickener having an emulsifying ability that is generally used for the purpose of obtaining an oil-in-water emulsion having good emulsion stability and usability.
- the oil-in-water emulsified cosmetic obtained by blending stearoxyhydroxypropylmethylcellulose was inferior in cosmetic effect.
- vesicles are formed by amphipathic substances, but nanodiscs are not attached to the oil-water interface.
- Example 1 and Example 2 which are the oil-in-water emulsified cosmetics of the present invention, were excellent in vibration stability and cosmetic effect. Further, the cosmetic of Example 4 in which the ratio of ethylhexyl methoxycinnamate to the total amount of the cosmetic of Example 3 and the ultraviolet absorber in which the surface hydrophobic treatment agent of the pigment was changed was 40% was also excellent. Vibration stability and cosmetic effect were obtained.
- Comparative Examples 5 to 7 containing no ethylhexyl methoxycinnamate as an ultraviolet absorber and ethylhexyl methoxycinnamate are contained the ratio of ethylhexyl methoxycinnamate to the total amount of the ultraviolet absorber is less than 40%.
- the cosmetic of Comparative Example 4 was inferior in vibration stability. Therefore, the oil-in-water emulsified cosmetic using (B) polyoxyalkylene-modified silicone and having the ratio of ethylhexyl methoxycinnamate to 40% or more of the total amount of the ultraviolet absorber has excellent vibration stability. It was found that it has excellent cosmetic effects such as familiarity with the skin, uniformity of the coating film, and lack of thick coating.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
(A)1価アルコールおよび2価アルコールから選択される水性成分、
(B)ポリオキシアルキレン変性シリコーン、
(C)紫外線吸収剤としてメトキシケイヒ酸エチルヘキシルを含む油分、
(D)疎水化表面を有する顔料、および、
(E)アニオン性界面活性剤
を含み、
前記(A)水性成分が、1価アルコール単独の場合には化粧料全量に対して1~15質量%であり、2価アルコール単独の場合には化粧料全量に対して1~20質量%であり、1価アルコールと2価アルコールとの組み合わせである場合にはその合計量が化粧料全量に対して1~45質量%であり、
前記(C)油分中に配合される紫外線吸収剤の合計量に対してメトキシケイヒ酸エチルヘキシルが占める割合が質量比にして40%以上である、水中油型乳化化粧料を提供する。
また、本発明に係る水中油型乳化化粧料においては、前記(B)ポリオキシアルキレン変性シリコーンからなるナノディスクが油水界面に付着していることを特徴とする。
本発明に係る化粧料に配合される(A)水性成分(以下、単に「(A)成分」と称する場合がある)は、1価アルコールおよび2価アルコールから選択される1種または2種以上を指す。
1価アルコールとしては、化粧料に通常用いられるものであれば特に限定されないが、エチルアルコール(エタノール)、ノルマルプロピルアルコール、イソプロピルアルコール等が挙げられ、本発明においては、エチルアルコールが好ましい。
2価アルコールとしては、化粧料に通常用いられるものであれば特に限定されないが、1,3-ブチレングリコール、ジプロピレングリコール等が挙げられ、本発明においては、ジプロピレングリコールが好ましい。
水相中1価アルコール濃度(%)/15+水相中2価アルコール濃度(質量%)/20≦1 (1)
本発明に係る化粧料に配合される(B)ポリオキシアルキレン変性シリコーン(以下、単に「(B)成分」と称する場合がある)は、疎水性基としてポリシロキサン構造、親水基としてポリオキシアルキレン構造を有する界面活性剤であり、ジメチコンのメチル基の一部をポリエチレングリコールで置換した水溶性のシリコーン系界面活性剤であることが好ましい。具体的には下記式(2)で表される。
-(CH2)a-(C2H4O)b-(C3H6O)c-R2 (3)
で示されるポリオキシアルキレン基であり、その他のAは水素又は炭素数1~6のアルキル基であり、それぞれ同一でも、独立に異なっていてもよい。式(3)中のR2は水素又は炭素数1~6のアルキル基であり、aは1~6、bは0~50、cは0~50の整数であり、b+cは少なくとも5以上である。前記式(2)のmは1~200の整数であり、nは0~50の整数である。
本発明の(B)ポリオキシアルキレン変性シリコーンとしては、グリフィンの式によるHLB計算においてHLBが10未満であることが好ましい。
本発明に係る化粧料に配合される(C)油分(以下、単に「(C)成分」と称する場合がある)は、紫外線吸収剤として少なくともメトキシケイヒ酸エチルヘキシルを含む油分を指す。本発明の(C)油分として、紫外線吸収剤であるメトキシケイヒ酸エチルヘキシルが単独で用いられてもよいし、メトキシケイヒ酸エチルヘキシルに加えて通常日焼け止め化粧料に用いられる他の紫外線吸収剤や他の油分が、特に限定することなく、適宜組み合わせて配合されてもよい。
本発明に係る化粧料に配合される(D)顔料(以下、単に「(D)成分」と称する場合がある)は、特に制限されないが、化粧料に通常用いられるものから適宜選択することができ、表面が疎水性である無機顔料を指す。具体例としては、酸化鉄(ベンガラ)、チタン酸鉄、γ-酸化鉄、黄酸化鉄、黄土、黒酸化鉄、カーボンブラック、低次酸化チタン、マンゴバイオレット、コバルトバイオレット、酸化クロム、水酸化クロム、チタン酸コバルト、群青、紺青等が挙げられる。なかでも、本発明の(D)顔料としては、黄酸化鉄、赤酸化鉄、黒酸化鉄等の顔料級酸化鉄、顔料級酸化チタン等を用いることが好ましい。ここで、顔料級とは平均粒子径が100nm~1μmのものをいう。
疎水化処理顔料級酸化チタンの市販品としては、OTS-2 SACHTLEBEN RC402(大東化成工業社製)、NHS-チタンCR-50(三好化成工業社製)等が挙げられる。
本発明に係る化粧料に配合される(E)アニオン性界面活性剤(以下、単に「(E)成分」と称する場合がある)は、通常化粧料に用いられるものであればよく、前記(B)ポリオキシアルキレン変性シリコーン等のシリコーン系界面活性剤以外のものであって、カルボン酸、スルホン酸、リン酸構造を有するもの等の陰イオン性の親水基を持つ界面活性剤をいう。アニオン性界面活性剤の配合によりナノディスクが安定化する。
また、(B)ポリオキシアルキレン変性シリコーンと(E)アニオン性界面活性剤との配合量比が質量比にして1:0 .01~1:0.06であることが好ましい。
よって、本発明に係る水中油型乳化化粧料は、ポリオキシアルキレン変性シリコーンからなるナノディスクが油水界面、つまり油相からなる油滴の周りに付着(局在)していることを特徴とする。前記ナノディスクは、その長径が20nm~1000nmである。
したがって、本発明に係る水中油型乳化化粧料の製造方法は、(A)水性成分と(B)ポリオキシアルキレン変性シリコーンとを混合してベシクルを形成するベシクル形成工程と、ベシクル形成工程で得られたベシクル分散液に、アニオン性界面活性剤を添加して混合液を得る工程と、前記工程によって得られた混合液に別途混合溶解した油性成分を攪拌およびせん断力を加えながら乳化させる乳化工程と、を備える。
調製した試料30mlを樹脂チューブに入れ、30分間、10Hz以上の条件で振動を与え、静置後の試料の乳化分離および粉末の凝集状態を目視により観察した。評価は以下の基準に基づいて行った。
A:乳化破壊や粉末の凝集が見られない。
B:乳化破壊や粉末の凝集があまり見られない。
C:乳化破壊や粉末の凝集が見られる。
D:乳化破壊や粉末の凝集が激しく見られる。
10名の専門パネルによる実使用試験によって評価した。具体的には、調製した試料を皮膚に塗布した際の化粧効果(肌へのなじみ、塗膜の均一性、厚塗りのなさ)について各々以下の基準に従って評価を行った。
A:10人中7人以上が良いと感じる。
B:10人中4~6人が良いと感じる。
C:10人中3人以下が良いと感じる。
表1に掲げた組成を有する水中油型乳化化粧料を調製した。具体的には、油性成分と粉末成分を攪拌混合した混合溶液を、別途攪拌混合して得た水性成分の混合溶液に攪拌しながら添加することによって、比較例1の水中油型乳化化粧料を得た。一方、エタノールとベシクルを形成する両親媒性物質(ポリオキシアルキレン変性シリコーン、ポリオキシエチレン硬化ヒマシ油)とを混合攪拌した後、他の水性成分を混合して水相溶液を得、この水相溶液にアニオン性界面活性剤を添加して混合溶液を得、油性成分および粉末成分を別途混合して得た油相溶液を、前記混合溶液に攪拌しながら分散することによって、実施例1~4および比較例2~7の水中油型乳化化粧料を得た。調製した試料について、前記した評価方法に従って振動安定性および化粧効果を評価した。結果は表中に示す。
*2:テトラメチルテトラハイドロジェンシクロテトラシロキサン処理酸化チタン
*3:テトラメチルテトラハイドロジェンシクロテトラシロキサン処理黄色酸化鉄
*4:テトラメチルテトラハイドロジェンシクロテトラシロキサン処理赤色酸化鉄
*5:テトラメチルテトラハイドロジェンシクロテトラシロキサン処理黒色酸化鉄
*6:アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン酸2Na、水酸化Al)処理酸化チタン
*7:アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン酸2Na、水酸化Al)処理黄色酸化鉄
*8:アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン酸2Na、水酸化Al)処理赤色酸化鉄
*9:アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン酸2Na、水酸化Al)処理黒色酸化鉄
よって、(B)ポリオキシアルキレン変性シリコーンを用い、かつ、紫外線吸収剤の合計量に対してメトキシケイヒ酸エチルヘキシルが占める割合を40%以上とした水中油型乳化化粧料は、優れた振動安定性を有し、肌へのなじみ、塗膜の均一性および厚塗りのなさといった化粧効果にも優れることがわかった。
以下に、本発明の水中油型乳化化粧料の処方例を挙げる。本発明はこれらの処方例によって何ら限定されるものではなく、特許請求の範囲によって特定されるものであることはいうまでもない。なお、配合量はすべて製品全量に対する質量%で表す。
成分名称 配合量(質量%)
水 残余
EDTA-3Na 0.05
グリセリン 2
1,3-ブチレングリコール 8
フェノキシエタノール 0.5
(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポ
リマー 0.5
ステアロキシヒドロキシプロピルメチルセルロース 0.1
キサンタンガム 0.1
ステアロイルメチルタウリンNa 0.01
エタノール 8
PEG-12ジメチコン 1.5
セバシン酸ジイソプロピル 8
シリコーン処理酸化チタン 5
シリコーン処理黄色酸化鉄 4
シリコーン処理赤色酸化鉄 2
シリコーン処理黒色酸化鉄 0.1
メトキシケイヒ酸エチルヘキシル 5
ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン
2
ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 2
セスキイソステアリン酸ソルビタン 0.5
イソステアリン酸 0.5
シリカ・シリコーン処理酸化亜鉛 12
成分名称 配合量(質量%)
水 残余
EDTA-3Na 0.05
グリセリン 2
1,3-ブチレングリコール 8
フェノキシエタノール 0.5
(ジメチルアクリルアミド/アクリロイルジメチルタウリンNa)クロスポ
リマー 0.5
ステアロキシヒドロキシプロピルメチルセルロース 0.1
キサンタンガム 0.1
ステアロイルメチルタウリンNa 0.01
エタノール 5
PEG-12ジメチコン 1.5
セバシン酸ジイソプロピル 8
アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン
酸2Na、水酸化Al)処理酸化チタン 5
アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン
酸2Na、水酸化Al)処理黄色酸化鉄 1
アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン
酸2Na、水酸化Al)処理赤色酸化鉄 4
アミノ酸・エステル(セバシン酸イソステアリル、ステアロイルグルタミン
酸2Na、水酸化Al)処理黒色酸化鉄 0.1
メトキシケイヒ酸エチルヘキシル 5
ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン
2
ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル 2
セスキイソステアリン酸ソルビタン 0.5
イソステアリン酸 0.5
シリカ・シリコーン処理酸化亜鉛 12
Claims (7)
- (A)1価アルコールおよび2価アルコールから選択される水性成分、
(B)ポリオキシアルキレン変性シリコーン、
(C)紫外線吸収剤としてメトキシケイヒ酸エチルヘキシルを含む油分、
(D)疎水化表面を有する顔料、および、
(E)アニオン性界面活性剤
を含み、
前記(A)水性成分が、1価アルコール単独の場合には化粧料全量に対して1~15質量%であり、2価アルコール単独の場合には化粧料全量に対して1~20質量%であり、1価アルコールと2価アルコールとの組み合わせである場合にはその合計配合量が化粧料全量に対して1~45質量%であり、
前記(C)油分中に配合される紫外線吸収剤の合計配合量に対してメトキシケイヒ酸エチルヘキシルが占める割合が質量比にして40%以上である、水中油型乳化化粧料。 - 前記(D)成分の平均粒子径が100nm~1μmである、請求項1に記載の水中油型乳化化粧料。
- 前記紫外線吸収剤の配合量が、化粧料全量に対して5~25質量%である、請求項1または2に記載の水中油型乳化化粧料。
- 前記(B)成分からなるナノディスクが油水界面に付着している、請求項1から3のいずれか一項に記載の水中油型乳化化粧料。
- 前記(B)成分が、PEG-12ジメチコンである、請求項1から4のいずれか一項に記載の水中油型乳化化粧料。
- 前記(E)アニオン性界面活性剤がN-アシルメチルタウリン塩である、請求項1から5のいずれか一項に記載の水中油型乳化化粧料。
- さらに、(F)美白剤を含む、請求項1から6のいずれか一項に記載の水中油型乳化化粧料。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022571036A JPWO2022137637A1 (ja) | 2020-12-25 | 2021-08-16 | |
CN202180079221.0A CN116685298A (zh) | 2020-12-25 | 2021-08-16 | 水包油型乳化化妆品 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPPCT/JP2020/048753 | 2020-12-25 | ||
JP2020048753 | 2020-12-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022137637A1 true WO2022137637A1 (ja) | 2022-06-30 |
Family
ID=82158916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/029916 WO2022137637A1 (ja) | 2020-12-25 | 2021-08-16 | 水中油型乳化化粧料 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2022137637A1 (ja) |
CN (1) | CN116685298A (ja) |
WO (1) | WO2022137637A1 (ja) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102236A (ja) * | 2007-10-22 | 2009-05-14 | Shiseido Co Ltd | 水中油型乳化組成物及びその製造方法 |
JP2014070032A (ja) * | 2012-09-28 | 2014-04-21 | Shiseido Co Ltd | 水中油型乳化組成物 |
JP2014214134A (ja) * | 2013-04-26 | 2014-11-17 | 株式会社 資生堂 | 水性組成物 |
JP2018076308A (ja) * | 2016-10-28 | 2018-05-17 | ロート製薬株式会社 | 外用組成物 |
-
2021
- 2021-08-16 WO PCT/JP2021/029916 patent/WO2022137637A1/ja active Application Filing
- 2021-08-16 JP JP2022571036A patent/JPWO2022137637A1/ja active Pending
- 2021-08-16 CN CN202180079221.0A patent/CN116685298A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009102236A (ja) * | 2007-10-22 | 2009-05-14 | Shiseido Co Ltd | 水中油型乳化組成物及びその製造方法 |
JP2014070032A (ja) * | 2012-09-28 | 2014-04-21 | Shiseido Co Ltd | 水中油型乳化組成物 |
JP2014214134A (ja) * | 2013-04-26 | 2014-11-17 | 株式会社 資生堂 | 水性組成物 |
JP2018076308A (ja) * | 2016-10-28 | 2018-05-17 | ロート製薬株式会社 | 外用組成物 |
Also Published As
Publication number | Publication date |
---|---|
CN116685298A (zh) | 2023-09-01 |
JPWO2022137637A1 (ja) | 2022-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101801410B1 (ko) | W/o 유화 화장료 | |
WO2007017921A1 (ja) | セルフタンニング化粧料 | |
JP5295440B2 (ja) | メーキャップ化粧料 | |
JP2016153437A (ja) | 油中水型乳化化粧料 | |
JP6005921B2 (ja) | 油中水型乳化化粧料 | |
US20100233220A1 (en) | Sol Composition Containing Organically Modified Clay Mineral Having Platy Particle Structure, Oily Gel Composition, And W/O Type Emulsion Composition Containing The Same | |
JP3727901B2 (ja) | 水中油型乳化化粧料 | |
JP2010235469A (ja) | 油中水型乳化化粧料 | |
JP6877537B2 (ja) | 油中水型化粧料 | |
JP7075261B2 (ja) | O/w/o型乳化化粧料 | |
JP2004269418A (ja) | 化粧料 | |
JP6418626B2 (ja) | 油中水型乳化組成物及び該組成物を用いた油中水型乳化化粧料 | |
JP6831737B2 (ja) | 水中油型化粧料 | |
JP5957384B2 (ja) | W/o乳化化粧料 | |
WO2022137637A1 (ja) | 水中油型乳化化粧料 | |
JP2001072532A (ja) | 水中油型乳化化粧料 | |
JP2018199657A (ja) | 油中水型乳化化粧料 | |
JP2021123590A (ja) | 油中水型乳化化粧料 | |
JP2004067628A (ja) | 油中水型乳化組成物 | |
JP5165978B2 (ja) | 油中水型固形乳化化粧料 | |
WO2022137636A1 (ja) | 水中油型日焼け止め化粧料 | |
WO2022137638A1 (ja) | 水中油型乳化化粧料 | |
WO2021177400A1 (ja) | 水中油型乳化組成物 | |
WO2023032832A1 (ja) | 水中油型乳化化粧料 | |
WO2021221149A1 (ja) | 水中油型乳化組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21909797 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2022571036 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180079221.0 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21909797 Country of ref document: EP Kind code of ref document: A1 |